- Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. Choi, J.H., Hur, J., Yoon, C.H., Kim, J.H., Lee, C.S., Youn, S.W., Oh, I.Y., Skurk, C., Murohara, T., Park, Y.B., Walsh, K., Kim, H.S. J. Biol. Chem. (2004)